Summary:
Bone marrow-derived mesenchymal stem cells (MSCs) are known to interact with hematopoietic stem cells (HSCs) and immune cells, and represent potential cellular therapy to enhance allogeneic hematopoietic engraftment and prevent graft-versus-host disease (GVHD). We investigated the role of human MSCs in NOD-SCID mice repopulation by unrelated human hematopoietic cells and studied the immune interactions between human MSCs and unrelated donor blood cells in vitro. When hematopoietic stem cell numbers were limited, human engraftment of NOD-SCID mice was observed only after coinfusion of unrelated human MSCs, but not with coinfusion of mouse mesenchymal cell line. Unrelated human MSCs did not elicit T-cell activation in vitro and suppressed T-cell activation by Tuberculin and unrelated allogeneic lymphocytes in a dose-dependent manner. Cell-free MSC culture supernatant, mouse stromal cells and human dermal fibroblasts did not elicit this effect. These preclinical data suggest that unrelated, human bone marrow-derived, culture-expanded MSCs may improve the outcome of allogeneic transplantation by promoting hematopoietic engraftment and limiting GVHD and their therapeutic potential should be tested in clinic.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Koç O, Lazarus H . Mesenchymal stem cells heading to the clinic. Bone Marrow Transplant 2001; 27: 235–239.
Bianco P, Constantini M, Dearden L, Bonucci E . Alkaline phosphatase positive precursors of adipocytes in the human bone marrow. Br J Haematol 1988; 68: 401–411.
Haynesworth S, Goshima J, Goldberg V, Caplan A . Characterization of cells with osteogenic potential from human marrow. Bone 1992; 13: 81–88.
Pittinger M, Mackay A, Beck S et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143–147.
Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41–49.
Reyes M, Lund T, Lenvik T et al. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 2001; 98: 2615–2625.
Toksoz D, Zsebo K, Smith K et al. Support of human hematopoiesis in long term bone marrow cultures by murine stromal cells selectively expressing the membrane bound and secreted forms of the human homologue of the steel gene product, stem cell factor. Proc Natl Acad Sci USA 1992; 89: 7350–7354.
Clark B, Keating A . Biology of bone marrow stroma. Ann NY Acad Sci 1995; 770: 70–88.
Majumdar M, Thiede M, Haynesworth S et al. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res 2001; 9: 841–848.
Majumdar MK, Thiede MA, Mosca JD et al. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 1998; 176: 186–192.
LeBlanc K, Tammik L, Sundberg B et al. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003; 57: 11–20.
Tse WT, Pendleton JD, Beyer WM et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003; 75: 389–397.
Di Nicola M, Carlo-Stella C, Magni M et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838.
Bartholomew A, Sturgeon C, Siatskas M et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 72: 1653–1655.
Caplan A . Mesenchymal stem cells. J Orthop Res 1991; 9: 641–650.
Haynesworth S, Baber M, Caplan A . Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 1992; 13: 69–80.
Koç O, Gerson S, Cooper B et al. Rapid hematopoietic recovery after co-infusion of autologous culture-expanded human mesenchymal stem cells (hMSCs) and PBPCs in breast cancer patients receiving high dose chemotherapy. J Clin Oncol 2000; 18: 307–316.
Koç O, Day J, Nieder M et al. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and hurler syndrome (MPS-IH). Bone Marrow Transplant 2002; 30: 215–222.
Schafer I, Pandy M, Ferguson R, Davis B . Comparative observation of fibroblasts derived from the papillary and reticular dermis of infants and adults: growth kinetics, packing density at confluence and surface morphology. Mech Ageing Dev 1985; 31: 275–293.
Dennis J, Merriam A, Awadallah A et al. A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J Bone Min Res 1999; 14: 700.
Tary-Lehmann M, Hricik D, Justice A et al. Enzyme-linked immunosorbent assay spot detection of interferon and interleukin-5 producing cells as a predictive marker for renal allograft failure. Transplantation 1998; 66: 219–224.
Laughlin MJ, Barker J, Bambach B et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344: 1815–1822.
Anklesaria P, Kase K, Glowacki J et al. Engraftment of a clonal bone marrow stromal cell line in vivo stimulates hematopoietic recovery from total body irradiation. Proc Natl Acad Sci USA 1987; 1987: 7681–7685.
Nolta J, Hanley M, Kohn D . Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: analysis of gene transduction of long-lived progenitors. Blood 1994; 83: 3041–3051.
Almeida-Porada G, Porada C, Tran N, Zanjani E . Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation. Blood 2000; 95: 3620–3627.
Noort WA, Kruisselbrink AB, Anker PS et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 2002; 30: 870–878.
Angelopoulou M, Novelli E, Grove J et al. Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice. Exp Hematol 2003; 31: 413–420.
Lee K, Gerson SL, Maitra B, Koc ON . G156A MGMT-transduced human mesenchymal stem cells can be selectively enriched by O6-benzylguanine and BCNU. J Hematother Stem Cell Res 2001; 10: 691–701.
Sandmaier B, Strob R, Kniley J et al. Evidence of allogeneic stromal engraftment in bone marrow using canine mesenchymal stem cells. Blood 1998; 92: 116a.
Devine S, Bartholomew A, Mahmud N et al. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol 2001; 29: 244–255.
Krampera M, Glennie S, Dyson J et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003; 101: 3722–3729.
Acknowledgements
We thank Dr Magdalena Tary-Lehmann for assistance with the Elispot assay, Stem Cell, Athymic Animal, Flow Cytometry and Radiation Resources Core Facilities of the Comprehensive Cancer Center of Case Western Reserve University and University Hospitals of Cleveland (P30 CA43703). This work was supported by NIH, R01HL62360 (PI: ON Koç).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maitra, B., Szekely, E., Gjini, K. et al. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant 33, 597–604 (2004). https://doi.org/10.1038/sj.bmt.1704400
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704400
Keywords
This article is cited by
-
Neglected No More: Emerging Cellular Therapies in Traumatic Injury
Stem Cell Reviews and Reports (2021)
-
Immunomodulation in leukemia: cellular aspects of anti-leukemic properties
Clinical and Translational Oncology (2020)
-
Biological functions of mesenchymal stem cells and clinical implications
Cellular and Molecular Life Sciences (2019)
-
Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases
Nature Reviews Nephrology (2018)
-
Mesenchymal stem cells: key players in cancer progression
Molecular Cancer (2017)